1109 related articles for article (PubMed ID: 20354260)
1. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids and inflammatory processes: from molecules to man.
Calder PC
Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases.
Giudetti AM; Cagnazzo R
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):57-67. PubMed ID: 23064030
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
[TBL] [Abstract][Full Text] [Related]
5. Omega-6 fatty acids and inflammation.
Innes JK; Calder PC
Prostaglandins Leukot Essent Fatty Acids; 2018 May; 132():41-48. PubMed ID: 29610056
[TBL] [Abstract][Full Text] [Related]
6. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
[TBL] [Abstract][Full Text] [Related]
7. Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell.
Weylandt KH
Eur J Pharmacol; 2016 Aug; 785():108-115. PubMed ID: 26546723
[TBL] [Abstract][Full Text] [Related]
8. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance.
Calder PC
Biochim Biophys Acta; 2015 Apr; 1851(4):469-84. PubMed ID: 25149823
[TBL] [Abstract][Full Text] [Related]
9. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
[TBL] [Abstract][Full Text] [Related]
10. Mammalian ALOX15 orthologs exhibit pronounced dual positional specificity with docosahexaenoic acid.
Kutzner L; Goloshchapova K; Heydeck D; Stehling S; Kuhn H; Schebb NH
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jul; 1862(7):666-675. PubMed ID: 28400162
[TBL] [Abstract][Full Text] [Related]
11. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale.
Calder PC
Biochimie; 2009 Jun; 91(6):791-5. PubMed ID: 19455748
[TBL] [Abstract][Full Text] [Related]
12. Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer.
Janakiram NB; Rao CV
Curr Mol Med; 2009 Jun; 9(5):565-79. PubMed ID: 19601807
[TBL] [Abstract][Full Text] [Related]
13. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.
Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Laiglesia LM; Martínez JA; Moreno-Aliaga MJ
J Physiol Biochem; 2015 Jun; 71(2):341-9. PubMed ID: 25752887
[TBL] [Abstract][Full Text] [Related]
14. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
Serhan CN; Chiang N; Dalli J
Semin Immunol; 2015 May; 27(3):200-15. PubMed ID: 25857211
[TBL] [Abstract][Full Text] [Related]
15. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
[TBL] [Abstract][Full Text] [Related]
16. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
Yacoubian S; Serhan CN
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612
[TBL] [Abstract][Full Text] [Related]
17. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis.
Lubrano V; Ndreu R; Balzan S
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675152
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
Molfino A; Amabile MI; Monti M; Muscaritoli M
Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
[TBL] [Abstract][Full Text] [Related]
19. Computational Modeling of Competitive Metabolism between ω3- and ω6-Polyunsaturated Fatty Acids in Inflammatory Macrophages.
Gupta S; Kihara Y; Maurya MR; Norris PC; Dennis EA; Subramaniam S
J Phys Chem B; 2016 Aug; 120(33):8346-53. PubMed ID: 27063350
[TBL] [Abstract][Full Text] [Related]
20. Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity.
Pearl DS; Masoodi M; Eiden M; Brümmer J; Gullick D; McKeever TM; Whittaker MA; Nitch-Smith H; Brown JF; Shute JK; Mills G; Calder PC; Trebble TM
J Crohns Colitis; 2014 Jan; 8(1):70-9. PubMed ID: 23619007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
